Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy | MicrobiomeTrials← Back to trialsNCT02531880
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-11-19Est. Completion: 2030-07-01
Enrollment target: 40 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Drug Resistant Epilepsy
The purpose of this study is to assess the safety and performance of the iVEAcare Neuromodulation System for the treatme…
Multiple LocationsEst. completion Jun 2027
Rett Syndrome
Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder caused primarily by mutations in the MECP2 gene, leadi…
Fortaleza, BrazilCompleted Jun 2027
Recruiting
ENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SC…
San Francisco, United StatesEst. completion Jan 2028